logo

For the Inventor, By the Inventor

Tainan, Taiwan

Ching-Wei Chen

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:

goldMedal12 out of 23 
 
Glac Biotech Co., Ltd.
 patents

Years Active: 2023-2024

Loading Chart...
12 patents (USPTO):Explore Patents
1. 12161682 - Topical composition and method of improving skin diseases and dermatitis using the same (2024-12-10),
2. 12016361 - Probiotic culture and use thereof (2024-06-25),
3. 12005091 - Use of lactic acid bacteria or fermentation product thereof for maintaining or improving gastrointestinal condition (2024-06-11),
4. 12005090 - Probiotic composition including lactic acid bacterial strains and use of at least one of such strains (2024-06-11),
5. 11999944 - Method for promoting growth of probiotic microorganism (2024-06-04),
6. 11969447 - Use of spray-dried powder derived from lactic acid bacterial strains and herbal extracts for promoting defecation (2024-04-30),
7. 11963987 - Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria (2024-04-23),
8. 11913047 - Method for producing γ-aminobutyric acid and fermented culture prepared thereby (2024-02-27),
9. 11896632 - Methods for inhibiting growth of oral pathogenic bacteria and alleviating oral pathogenic bacteria-associated disorder (2024-02-13),
10. 11865147 - Methods for reducing purine content and alleviating disorder of uric acid metabolism (2024-01-09),
11. 11801274 - Method for alleviating atopic dermatitis (2023-10-31),
12. 11717546 - Composition for promoting defecation and use therefor (2023-08-08),

Title: Innovations by Ching-Wei Chen

Introduction

Ching-Wei Chen is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of biotechnology, particularly in developing topical compositions for skin diseases and dermatitis. With a total of 12 patents to his name, Chen's work reflects a commitment to improving health and wellness through innovative solutions.

Latest Patents

Among his latest patents is a topical composition aimed at improving skin diseases and dermatitis. This invention utilizes a fermented product of lactic acid bacteria synbiotics as an active ingredient. The fermentation process involves lactic acid bacteria and a deactivating step on a fermenting substrate, which includes animal protein, plant protein, and/or plant extracts. This innovative composition effectively inhibits the growth of harmful pathogens and can be used in various topical applications. Another significant patent is related to a probiotic culture prepared by cultivating a probiotic mixture in a collagen solution. This mixture includes specific strains of lactic acid bacteria, which are deposited at recognized culture collection centers. The probiotic culture is designed to improve skin conditions and inhibit pathogenic infections.

Career Highlights

Ching-Wei Chen is currently associated with Glac Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in dermatology and skin health.

Collaborations

Chen collaborates with several professionals in his field, including Hsieh-Hsun Ho and Yi-Wei Kuo, who contribute to his innovative projects and research initiatives.

Conclusion

Ching-Wei Chen's contributions to biotechnology and dermatology through his patents demonstrate his dedication to innovation and improving health outcomes. His work continues to inspire advancements in the treatment of skin diseases and the development of effective probiotic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…